Navigation Links
Hospital-based smoking cessation program after heart attack adds to success
Date:10/13/2008

Hospital-based smoking cessation programs, along with referrals to cardiac rehabilitation, appear to be associated with increased rates of quitting smoking following heart attack, according to a report in the Oct. 13, 2008, issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Emory University researchers studied 639 patients who smoked at the time of their hospitalization for heart attack. Six months later, 297 of the patients approximately 47 percent of them - had quit smoking.

The odds of quitting were greater among patients who received discharge recommendations for cardiac rehabilitation and those who were treated at a facility offering an inpatient smoking cessation program. However, individual counseling was not associated with quit rates.

"The findings are important because cardiac rehabilitation and hospital-based smoking cessation programs appear to be under-utilized in current clinical practice and should be potentially considered as a structural measure of health care quality for patients with heart attack," says Susmita Parashar, MD, MPH, division of cardiology, Emory University School of Medicine.

Parashar, one of the study authors, says the study shows that patients recovering from a heart attack are more likely to quit smoking if they are referred to a cardiac rehabilitation program or if a hospital-based smoking cessation program is available to them.

On the contrary, individual counseling to quit smoking by health care professionals during a heart attack hospitalization does not predict successful quitting.


'/>"/>

Contact: Jennifer Johnson
jrjohn9@emory.edu
404-727-5696
Emory University
Source:Eurekalert

Page: 1

Related medicine news :

1. Study quantifies cost-benefit of hospital-based program to keep youth out of prison
2. Sutter Opens Countys First Non-Hospital-Based Nuclear Imaging Option
3. Smoking may strongly increase long-term risk of eye disease
4. Smoking increases risks for head and neck cancers for men and women
5. Smoking Boosts Risk for Head, Neck Cancers
6. AUDIO from Medialink and Commit Lozenge: Wanna Quit Smoking With Therapeutic Nicotine? Just Follow the Directions
7. Passive smoking increases sleep disturbance among pregnant women
8. Teens who see more smoking in movies may have increased risk of becoming established smokers
9. Smoking in Movies May Put Teens at Risk
10. Test Spots Genetic Damage Done by Smoking
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... application containerization, today announced it will co-exhibit with technology partners LG Business Solutions ... at the Marriott Metro Center in Washington D.C., will provide education and examination ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... the CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds ... highest industry standards and specifications such as ANSI, ISO and proven test methods ...
(Date:3/27/2017)... ... 2017 , ... Osteitis pubis may be commonplace and seemingly ... occurs when the muscles around the pelvis become inflamed. Over time, untreated osteitis ... as well as accompanying tenderness and weakness. Without proper intervention, it can hinder ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek , a Farmingdale, ... recent RNA methylation “gold rush” with their established portfolio of optimized assay kits ... N6-methyladenosine, or m6A , RNA methylation has received a new burst in ...
(Date:3/27/2017)... San Mateo, CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still ... one of the best days I’ve had in a long time,” she said. , She ... a lot of money that I never thought I would have to help my students.” ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology: